Method of manufacturing a bioimplant

US12226550B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12226550-B2
Application numberUS-202218086506-A
CountryUS
Kind codeB2
Filing dateDec 21, 2022
Priority dateFeb 3, 2012
Publication dateFeb 18, 2025
Grant dateFeb 18, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a bioimplant which is capable to inhibit the biofilm formation over a long period of time after an operation. The bioimplant of the present invention comprises a base material of metal, ceramic, or plastic and a thermal spraying film of a calcium phosphate-based material formed at least partially thereon and the silver concentration in the thermal-spray film is 0.05 wt % to 3.00 wt %.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of manufacturing a bioimplant, comprising: providing a base material of the bioimplant; forming a coating comprising a calcium phosphate-based material and a silver material on at least a part of a surface of the base material; after forming the coating, heating the coating at a predetermined temperature under a predetermined pressure to form oxyapatite in the coating; and immersing the coating in purified water to convert oxyapatite present in the coating to hydroxyapatite, wherein the immersing results in fine crystals of the hydroxyapatite being formed on a surface of the coating, wherein a size of the fine crystals of hydroxyapatite is in a range of 0.01 μm to 2.00 μm in length, thickness or width, and wherein a temperature of the purified water is in a range of 60 to 100 degrees Celsius. 2. The method according to claim 1 , wherein said calcium phosphate-based material is a compound or a mixture of two or more compounds selected from the group consisting of hydroxyapatite, alpha-tricalcium phosphate, beta-tricalcium phosphate, and tetracalcium phosphate. 3. The method according to claim 1 , wherein the base material comprises a metal. 4. The method according to claim 1 , wherein the base material comprises ceramic. 5. The method according to claim 1 , wherein the base material comprises a plastic. 6. The method according to claim 1 , wherein: the heating is performed at a temperature range of 550 to 850 degrees Celsius for a period of time in the range of 1 to 5 hours; and the immersing is performed for a period of time in the range of 10 to 60 μminutes. 7. The method according to claim 1 , wherein the resulting coating comprises a silver concentration in the range of 0.05 wt % to 3.00 wt %. 8. The method according to claim 1 , wherein the forming the coating is performed by applying a thermal sprayed film comprising a calcium phosphate-based material and a silver material.

Assignees

Inventors

Classifications

  • Silver, e.g. silver sulfadiazine · CPC title

  • Biocides, antimicrobial agents, antiseptic agents · CPC title

  • Methods for coating medical devices · CPC title

  • Phosphorus-containing materials, e.g. apatite · CPC title

  • A61L27/54Primary

    Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12226550B2 cover?
Provided is a bioimplant which is capable to inhibit the biofilm formation over a long period of time after an operation. The bioimplant of the present invention comprises a base material of metal, ceramic, or plastic and a thermal spraying film of a calcium phosphate-based material formed at least partially thereon and the silver concentration in the thermal-spray film is 0.05 wt % to 3.00 wt %.
Who is the assignee on this patent?
Univ Saga, Kyocera Corp
What technology area does this patent fall under?
Primary CPC classification A61L27/54. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).